SUPERNUS PHARMACEUTICALS, INC. (SUPN) Operating income 2016–2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) annual operating income history from SEC filings — each fiscal year as reported.
-$62.3MFY2025 · since FY2016: $54.2M → -$62.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.3M | -176.3% |
| FY2024 | $81.7M | +1649.9% |
| FY2023 | -$5.3M | -111.4% |
| FY2022 | $46.1M | -46.4% |
| FY2021 | $86.0M | -50.5% |
| FY2020 | $173.7M | +16.9% |
| FY2019 | $148.6M | +2.9% |
| FY2018 | $144.4M | +45.1% |
| FY2017 | $99.5M | +83.6% |
| FY2016 | $54.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice